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ABSTRACT

Although implants made with bioactive glass have shown promising results for
bone repair, their application in repairing load-bearing long bones is limited due to their
poor mechanical properties as compared to human bones. This thesis study is on freeform
extrusion fabrication of silicate based 13-93 bioactive glass scaffolds reinforced with
titanium fibers. A composite paste was prepared with 13-93 bioactive glass filled with
titanium fibers (~16 µm in diameter and aspect ratio of ~250) having 0.1 to 0.4 vol. % of
the bioactive glass scaffold. This paste was then filled into a syringe manually, and then
extruded through a nozzle to fabricate scaffolds with an extrudate diameter of about ~0.8
mm. The sintered scaffolds, with and without titanium fibers, had measured pore sizes
ranging from 400 to 800 µm and a porosity of ~50%. Scaffolds produced with 0.4 vol. %
titanium fibers were measured to have a fracture toughness of ~0.8 MPa•m1/2 and a flexural
strength of ~15 MPa .Bioactive glass scaffolds without titanium fibers had a toughness of
~0.5 MPa•m1/2 and strength of ~10 MPa. The addition of titanium fibers increased the
fracture toughness of the scaffolds by ~70% and flexural strength by ~40%. The scaffolds’
biocompatibility and their degradation in mechanical properties in vitro were assessed by
immersing the scaffolds in a simulated body fluid over a period of one to four weeks.
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1. INTRODUCTION

Bone possesses the intrinsic capacity for regeneration as part of the repair process
in response to injury, as well as during skeletal development or continuous remodeling
throughout adult life [1, 2]. Segmental bone defects and multiple fractures constitute a
major portion of the musculoskeletal disorders seen in human beings. The current
approaches towards treatment of such disorders include the use of intramedullary nailing,
use of plates, and external fixations. The limitations associated with such methods include
prolonged course, poor reliability, high complication rate, and poor healing rates [3].
Another sophisticated and established method of treatment of bone repairs is the use of
allografts. But the lack of structural integrity, limited availability, and morbidity of the
donor site pose serious limitation to this approach [4].

Over the past 10 years, biomaterials have been widely used in bone repair
applications [5, 6]. A large number of synthetic substitutes like hydroxyapatite, calcium
phosphate cements and glass ceramics have been investigated for bone repair [7, 8, 9, 10,
11, 12]. Even though the above materials have osteoconductive and osteoinductive
properties, they provide minimal structural support. Fu et al.[13], Liu et al.[14], Kolan et
al.[15], Doiphode et al[16]., and Rahaman et al.[17] studied the use of 13-93 bioactive
glass in fabricating scaffolds for bone repair using a variety of fabrication techniques
including slip casting, polymer foam replication, selective laser sintering, and robocasting.
The investigation into mechanical and biological properties of the fabricated scaffolds has
shown that 13-93 glass has favorable properties in repairing segmental bone defects [18,
19].
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Most of the previous studies on 13-93 bioactive glass (bioglass) done by Rahaman
et al. [18,19] have shown that the mechanical properties of 13-93 scaffolds fabricated by
extrusion deposition are promising for applications in loaded bone repair. In-vivo
assessment of 13-93 bioglass has shown good bonding between the scaffold and the
surrounding tissues, in addition to new bone and tissue growth around the scaffold [20, 21,
22]. However within four weeks of implantation, cracks were generated on the surface of
the scaffolds due to reaction of the bioglass with blood, resulting in the formation of
hydroxyapatite [23]. These cracks could potentially cause failure of the implant. Other
bioglasses with slower conversion rates could be used for implants, but at the expense of
unconverted glass that will remain in the host body.

As to provide more structural integrity for the scaffolds, we propose addition of
ductile metallic fibers into the bioglass matrix to form a composite with improved
toughness. The addition of metallic fibers is expected to improve the ductility and lower
the rate of degradation in vivo of the sintered scaffolds. Previous studies have shown that
the strength and toughness of glasses are improved upon dispersion of metallic particles in
them [24, 25, 26].

In this study, titanium fibers are used to reinforce the bioglass matrix for fabrication
of scaffolds. Titanium is used due to the following reasons:1) titanium is an FDA approved,
widely used material for synthetic implants as it offers excellent biocompatibility; 2) the
thermal coefficients of expansion of the titanium fiber and bioactive glass are close to each
other, thereby reducing the localized thermal stresses that may be generated during the
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fabrication process; and 3) the presence of silica in bioglass matrix and titanium oxide on
the surface of titanium fibers will essentially provide good adhesion between these
materials, thereby avoiding problems like de-bonding and voids.

Several additive manufacturing techniques are used in the fabrication of bioglass
scaffolds. Cesarano et al. [27] used robocasting technique to fabricate HA latticework
structures for load bearing bone repair applications. Lorrison et al. [28] used selective laser
sintering to fabricate glass/ceramic scaffolds. Fused deposition modeling of latticework
scaffolds and extrusion of hydroxyapatite on the scaffolds was done by Cristina et al. [29]
to fabricate scaffolds with high density. Simpson et al. [30] and Krishna et al. [31] studied
the effect of pore sizes and pore geometry on mechanical and biological properties of
scaffolds manufactured by selective laser sintering. 3D printing was also used to fabricate
cell-laden poly (ɛ-caprolactone)/alginate hybrid scaffolds that showed over 83% cell
proliferation and uniform distribution [32]. Foam replication technique was used by Chen
et al. [33] to fabricate highly porous (90%) bioactive glass scaffolds. But most of the
scaffolds fabricated using additive manufacturing techniques had low toughness compared
to conventional methods like hot pressing.

This study aims at fabricating titanium reinforced glass scaffolds using freeform
extrusion on to a hot plate. An aqueous paste mix of 13-39 silicate bioactive glass, binders
and titanium fibers were made for extrusion. Four types of scaffolds, each having different
quantities of titanium fibers (0, 0.2, 0.3 and 0.4 vol. %) were fabricated and their heat
treatment schedule was identified. Following this a comprehensive evaluation of its
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mechanical and biological properties was done. The mechanical properties tested include
fracture toughness, flexural strength and compressive strength. In addition to this,
bioactivity and degradation of mechanical strength in vitro were also assessed.
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2. EXPERIMENTAL PROCEDURE

2.1. FABRICATION EQUIPMENT

A 3D printer that extrudes material onto a hot plate (Figure 2.1) is used for the
fabrication of scaffolds. It primarily consists of extrusion devices, a motion subsystem and
a real time control sub-system. The printer has X, Y and Z-axis motion capabilities
controlled by three stepper motors (Empire Magnetics, Rohnert Park, CA). A ram extruder
is used to provide the extrusion force.

Extrusion system
(Step motor and load cell)

Z axis

Syringe & needle
Hot plate
Y axis

X axis

Figure 2.1. Overview of the machine used in the fabrication process
The paste in the syringe (60 cc plastic syringe) is extruded through a 1.19 mm
nozzle (Nordson EFD, Westlake, OH) on to a hot plate set at 40 °C as shown in Figure 2.1.
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After the completion of one layer, the gantry moves up by the thickness of one layer. These
steps are repeated until the entire part is formed. For printing a scaffold, the scaffold
geometry was modeled in NX 9.0 (CAD software from Siemens, Inc.) with the desired
dimensions (40 x 36 x 6 mm3), raster patterns, and pore size (800 µm) and later exported
to the printer as G codes.

2.2. PREPARATION OF PASTE

The as-received water quenched 13-93 bioactive glass (50-56% silica, 17-23%
calcium oxide, 3-5% phosphorous pentoxide, 5-7% sodium oxide, 10-14% potassium
oxide, and 4-6% magnesium oxide, where the chemical composition is in weight.%) was
crushed in a steel shatterbox (SPEX SamplePrep Crusher, Model 8500, Metuchen, NJ) and
attrition-milled using de-ionized water for 3 h with ZrO2 as the grinding medium. The
particles’ size distribution was measured using a laser diffraction-based particle size
analyzer (Model LS 13 320; Beckman Coulter Inc., Fullerton, CA). To make an extrudable
paste, the milled 13-93 bioactive glass particles were mixed with de-ionized water and
additives including binder and dispersant. The mixture was then ball-milled for 18h with
zirconium (grinding medium). Following milling, the mixture was heated for about 50 min
at 70°C with continuous stirring along with the simultaneous addition of a thickening agent
(Methocel) into the paste mix. Different types of pastes were used in this research with
varying volume concentrations of titanium fibers (0.0, 0.2, 0.3 and 0.4 vol. %). For
preparing a paste with fibers, the fibers were added to the stirring mix along with methocel.
This ensured uniform distribution of fibers within the paste. Following this the paste was
vacuum-mixed for 4-5 min (WhipMix Vacuum Power Mixer Plus; WhipMix Corporation,

7
Louisville, KY) so as to remove any air bubbles present and then transferred into an airtight container. Figure 2.2 shows a paste with 0.3 vol. % of titanium fibers distributed in it.
Since the fibers are added during the preparation of paste itself, a homogenous distribution
is attained. The paste composition used is given in Table 2.1.

Figure 2.2. Paste with titanium fibers distributed in bioglass

Table 2.1. Titanium reinforced 13-39 bioactive glass paste composition
Component

Concentration

Manufacturer

(vol. %)
13-93 Glass particles

40

Mo-Sci Corp, Rolla, MO

Darvan C

2

Vanderbilt Minerals LLC,
Norwalk, CT

Methocel

4.0 – 4.4

Dow Chemical Company,
Midland, MI

Titanium fiber

0.0 - 0.4

Intramicron LLC, Auburn,
AL

De-ionized water

54

-
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2.3. MATERIAL CHARACTERIZATION
The surface morphology of the scaffold was observed under a scanning electron
microscope (S-4700; Hitachi, Tokyo, Japan) after coating it with Au/Pd. To analyze the
presence of any crystalline phases in the as-received glass particles or in the sintered
scaffold, X-ray diffraction (Philips X-Pert, Westborough, MA) was used. XRD was also
used to check for the presence of hydroxyapatite on the surface of the scaffold, immersed
in simulated body fluid (SBF). The surface of titanium fiber was examined for presence of
oxides and carbides using an X-ray photoelectron spectrometer (Kratos Axis 165
Photoelectron Spectrometer, Manchester, UK).

2.4. POST PROCESSING

Thermogravimetric analysis (TGA) (NETZSCH STA 409 simultaneous thermal

analyzer, Burlington, MA) was done on the green parts made with and without titanium
fiber in order to identify the post processing schedule. The rate of heating, temperature
holds, and sintering temperature were determined from the TGA results. Scanning electron
microscopy (Hitachi S-4700 FESEM, Hitachi Co., Tokyo, Japan) images of green and
sintered scaffolds were taken during most of the manufacturing and testing phases to look
for visual clues towards defects in the scaffolds. X-ray diffraction (Philips X-Pert,
Westborough, MA) run over 2θ range of 10° – 90° was used to identify the amorphous
nature of sintered glass, as well as presence of titanium using Cu Kα radiation (λ =
0.154056 nm).

9
2.5. MECHANICAL PROPERTIES

Flexure Test. Scaffolds (3 x 5 x 25 mm3) with different volume fraction of
titanium fibers were tested in flexure using an Instron testing machine (model 5881,
Norwood, MA). Prior to testing, surface grinding (FSG-618, Chevalier Machinery Inc.,
Santa Fe Springs, CA) was done to prepare parallel contact surfaces. A four point semiarticulated fixture (outer span of 20 mm and inner span of 10 mm) at a cross head speed of
0.2 mm/min using a 2 kN load cell was used in the flexure test and the load was applied
along the z direction. The flexural stress was determined using the following equation
(based on ASTM C1674-11):

𝜎=

3𝑃𝑙
4𝑏𝑑2

where P is the applied force, l is the length of the outer span, b is the width and d is the
thickness of the sample. The strength of the samples tested is expressed as mean ± standard
deviation (SD).

2.5.2 Fracture Toughness Test. A chevron notched beam test was used to assess
the fracture toughness of the scaffolds (3 x 5 x 25 mm3). A notch was made at the mid span
of the scaffold using a dicing saw (Accu-Cut 5200, AREMCO Products Inc., Ossining,
NY) with a 0.15 mm thick diamond blade. A four-point, semi-articulated fixture mentioned
above was used for this testing too. The fracture toughness was calculated using the
following equation (based on ASTM C1421-10):
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𝐾𝑐 = 𝐹𝑚 𝑌 ∗ 𝑚𝑖𝑛 (𝑆𝑜 − 𝑆𝑖 )10−6 /𝐵𝑊 3/2
where Kc is the fracture toughness, Fm is the maximum load, So and Si are outer and inner
spans of the fixture used, B is the depth, and W is the width of the specimen. Y*min is the
minimum of the geometric function (calculated based on ASTM C1421-10 guidelines). At
least six samples each were tested for different levels of fiber. The toughness is expressed
as mean ± standard deviation (SD).

2.6. IN VITRO ASSESSMENT OF SCAFFOLDS
For in vitro assessment two different scaffolds were used, one without fiber and
one with 0.3 vol. % fiber. As-fabricated scaffolds (5 x 5 x 5 mm3) were cleaned thrice in
distilled water and then by ethanol using an ultrasonic cleaner (Crest CP 500T, Trenton,
NJ), and dried overnight at 65 ℃ . The scaffolds were then weighed and immersed in
simulated body fluid (SBF) prepared according to the Kokubo method with a starting pH
of 7.40. 100 ml of SBF solution was used per gram of the scaffold, and the scaffold and
SBF solution were placed in plastic Nalgene bottles. The samples were then kept in an
incubator maintained at 37℃. Scaffolds were removed every week until four weeks, and
then dried overnight. The following assessments were then performed.

2.6.1. Degradation of Compressive Strength in SBF. The scaffolds removed
from SBF were tested in compression using an Instron testing machine (model 5881,
Norwood, MA) at a crosshead speed of 0.5 mm/min using a 10 kN load cell. As mentioned,
prior to testing the scaffolds were dried at 65℃ overnight. The compressive strength was
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calculated by dividing the force by cross-sectional area. Five samples were used for
compressive strength assessment and the strength is reported as mean ± SD.

2.6.2. Weight Loss of Scaffolds in SBF. Weight of the scaffolds were measured
before immersing in SBF solution. After removal the weight was measured only after
drying them overnight at 65℃. The weight loss was calculated according to the following
formula.

𝑊𝑒𝑖𝑔ℎ𝑡 𝐿𝑜𝑠𝑠 =

𝑊𝑏 − 𝑊𝑎
× 100
𝑊𝑏

where Wb is the initial dry weight of the sample and Wa is the dry weight of the sample after
removal from SBF. The weight loss percentage is plotted against immersion time as to
investigate physical and chemical changes to the scaffolds.

2.6.3. Quantification of Titanium Ion Release to SBF Solution. Inductively
coupled plasma mass spectrometry (ICP-MS) was used to quantify the amount of any
titanium related compounds/ions released from scaffolds to the SBF solution. A NexION
350D ICP-MS (PerkinElmer, Waltham, MA) instrument was used for conducting the
study. This test can detect traces of elements to parts per billion levels. The estimated Ti
instrument detection limit is 0.25 μg/L, instrument quantification limit is 0.5 μg/L, and
quantification method detection limit (MDL) is 2.5 μg/L. The operating conditions used
are listed in Table 2.2.

12
Table 2.2: Operating conditions for the ICP-MS test
ICP-MS Operating Condition
Nebulizer Gas Flow (L/min)

1.04*

Auxiliary Gas Flow (L/min)

1.2

Plasma Gas Flow (L/min)

18

ICP RF Power (W)

1600

Analog Stage Voltage (V)

-1675

Pulse Stage Voltage (V)

1400

Cell Entrance Voltage (V)

-2

Cell Exit Voltage (V)

-2

Cell Rod Offset

-15

Sampler Cones

Platinum

Skimmer Cones

Platinum

Sample Introduction System
Analyte
Dwell Time (ms)

Cyclonic Spray Chamber with Meinhard Nebulizer
Ti-47, Ti-49
50
*

Optimized daily
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3. RESULTS AND DISCUSSION

3.1. FABRICATION OF SCAFFOLDS

The size distribution of attrition-milled glass particles is shown in Figure 3.1.a. The
particles size varied from ~0.2 to ~12 µm with an average of 2.3 µm. The SEM images of
the as-received and attrition-milled bioglass are given in Figure 3.1.b and 3.1.c
respectively. A typical irregular shape of the milled glass particles can be observed which
will aid in achieving appropriate viscous flow characteristics during sintering. The irregular
shape combined with small particle size could potentially reduce the micro pores in the
scaffolds.

Figure 3.1. (a) Particle size distribution of attrition-milled bioglass (b) SEM image of the
as-received glass particles (c) SEM image of attrition-milled glass particles.
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The fabrication process consists of three basic steps: preparing the paste, printing
the scaffolds, and sintering them. The attrition-milled bioglass was mixed with the
additives listed in Table 2.1 to create a paste. The amount of titanium added to this paste
varied based on the desired volume fraction. The paste making process is explained in
detail in the appendix.

Scaffolds were fabricated using the extrusion fabrication machine (Figure 2.1). The
prepared paste is filled into a syringe manually and is extruded onto a hot plate maintained
at 40℃ using layer by layer deposition through a 1.19 mm diameter nozzle (Nordson EFD,
Ohio, USA). The extrusion force used varied between 200 N and 320 N based on the
amount of titanium fibers in the paste and the viscosity of the paste. An as-fabricated
scaffold with a 0.3% volume fraction of fibers in it is depicted in Figure 3.2. The green
scaffold was 40 mm x 36 mm x 6.0 mm in size and the pore sizes varied from 750 to 1000
µm.

Figure 3.2. An as-fabricated scaffold with 0.3 vol. % titanium fiber.
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Figure 3.3. Thermogravimetric analysis of paste
The binder burnout schedule for the ‘green scaffold’ was developed from the
thermogravimetric curve in Figure 3.3. This curve shows the changes in weight of the
‘green scaffold’ as a function of increasing temperature. Noticeable changes in the weight
of the scaffold were observed at approximately 100 °C and 300 ℃. The residual water
evaporates at 80-120 ℃ and Methocel and Darvan C burn out at around 300-350 ℃.
Holding temperatures were designed based on the curve, as to aid slow burn-out of the
additives in the scaffold. These observations were used to prepare the binder burnout and
sintering schedule in Table 3.1.
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Table 3.1. Binder Burnout Schedule
Starting

Ending

Heating Rate

Temperature (℃)

Temperature (℃)

Hold Period (h)

(℃/min)

20

350

0.3

2

350

700

2

1

700

50

10

-

A sintered scaffold with 0.4 vol. % fiber is pictured in Figure 3.4.a. Shrinkage was
observed in the final sintered part. The average shrinkage in the scaffold length, width and
thickness was 25%, 29% and 17%, respectively. The pore sizes varied from 600 – 850 µm.
Optical images (Figure 3.4.b, c) of the sintered scaffolds (shown in Figure 3.4.a) reveal
that the fibers are dispersed in the glass matrix. Figure 3.c shows the sintered part a higher
magnification. The Ti fibers oriented along the direction of the extruded filament can also
be clearly observed in Figure 3.4.c.
a

b

c

Figure 3.4. (a) Sintered 13-93 glass scaffold with 0.4 vol. % titanium fibers and (b) (c)
Optical images of the corresponding scaffolds
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XRD was conducted to verify that the sintered glass scaffold had an amorphous
structure. The XRD patterns of both the sintered scaffold and the starting glass particles
were found to have similar ‘bumps’ characteristic of amorphous materials under XRD
(Figure 3.5). In an amorphous phase, i.e., when the atoms are randomly organized in the
3D space, X-rays will be scattered in many directions. This leads to large bumps along the
2Ɵ angle in the XRD patterns. These patterns made it clear that no considerable amount of
crystallization was present in the final sintered scaffolds. XRD was also done on scaffolds
that had different volume fractions of titanium fibers. All of the patterns revealed the
amorphous nature of the final part. The XRD patterns of the scaffolds that had 0.4 vol. %
fibers and as-received titanium fibers are given in Figure 3.6. The matching titanium fiber
peaks (marked by red stars) in the scaffold with 0.4 vol% fiber can be seen in the XRD
pattern.

(b)

As-received glass particles

(a) Sintered scaffold without fibers

Figure 3.5. The XRD patterns of (a) a sintered scaffold without fibers and (b) a scaffold
with as-received glass particles.
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(a) Sintered scaffold with fibers

(b) Titanium fibers

Figure 3.6. The XRD patterns of (a) a sintered scaffold with fibers and (b) the as received
titanium fibers.

The titanium fibers had an average diameter of 16 µm and aspect ratio of 250. Their
surface chemistry and morphology were each studied so as to better understand the fiber’s
bonding properties with the glass matrix. The SEM images of the fibers at varying
magnifications are given in Figure 3.7. The fiber has uneven surface with irregularities that
will help the glass matrix to better bond to the fiber and will aid in avoiding possible debonding during sintering process.
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Figure 3.7 SEM images of fibers that reveal their rough surface.

XPS analysis was conducted on the fiber surface to analyze the surface chemistry
of the fibers. In XPS analysis, X-rays are used to irradiate the surface of a material. The Xrays excite the electrons of the atoms on the surface of the material. If the X-ray energy is
higher than the binding energy, electrons will be emitted from the surface. The kinetic
energy of the emitted electrons is measured and subtracted from the incident energy of the
X-ray to obtain the binding energy of that electron. From this, the element of atom can be
determined. Further based on what element the parent atom is bonded to, the binding
energy of the emitted electrons will vary. The instrument is capable of measuring such
energy shifts. From this data, the chemical composition of any compound present of the
surface could be determined. So essentially XPS result is a series of intensity peaks
corresponding to binding energies of the photoelectrons emitted from the surface of the
material. XPS can typically analyze the extreme outer thin layer (10-100 Angstroms) of a
material. Figure 3.8 shows the pattern obtained after performing XPS analysis on the
surface of the titanium fibers. The peaks for oxygen, titanium and carbon can be seen
clearly from the pattern. Figure 3.9 shows the XPS pattern of the Ti-2p3 region from the
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XPS pattern obtained. The peak for Ti 2p3 electron has convoluted peaks. The 2p3 binding
energy values of these peaks are 457.60 eV, 459.2 eV and 462.8 eV. CasaXPS software
was used to study the curve. These binding energy values correspond to titanium oxide,
elemental titanium, and titanium carbide respectively. The presence of titanium oxides and
carbides could result in slight changes in the thermal expansion coefficient of fibers. But
after sintering, no observable de-bonding of fibers was observed.

(a)

Figure 3.8. XPS pattern of (a) titanium fiber surface.
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(b)

Figure 3.9. Detailed XPS pattern for Ti-2p3 peak observed in Figure 3.8
3.2. MECHANICAL PROPERTIES OF SCAFFOLDS

The flexural strength of scaffolds with varying vol. % of titanium fibers are
summarized in Table 3.2. This strength varied from 10.4 MPa (0 vol. % of titanium fibers)
to 14.9 Mpa (0.4 vol. % of titanium fibers). The flexural strength increased as the Ti fiber
volume fraction increased. Previous mechanical testing studies on 13-93 bioglass scaffolds
prepared by robocasting studies have shown that the value of flexural strength of 13-93
bioactive glass is in the range of 11 ± 3 MPa [18]. These values are similar to those obtained
in this study. The flexural strength and flexural modulus of scaffolds with varying vol. %
of fibers is listed in Table 3.2. The flexural modulus of the scaffolds increased to 15 GPa
from 11 GPa due to addition of 0.4 vol. % titanium fibers into the scaffold. The trend in
modulus clearly shows that the flexural strength increases with addition of fibers. The
flexural strength reported in this study is similar to that of human trabecular bone (10-20
MPa) [34, 35].
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Table 3.2 Flexural strength and flexural modulus of scaffolds with varying vol. % of
titanium fibers
Fiber
Volume
Fraction

#

Flexural
Strength

Average

Standard
Deviation

Average

Standard
Deviation

2.4

10.24
12.79
9.1
11.02
10.96
13.3
9.87
12.15

11.2

2.1

1.8

7.1
9.65
7.99
12.91
15.52
8.56
14.03
15.7

11.4

4.3

1.9

13.65
16.93
10.6
14.37
11.12
12.49
17
15.88

13.8

3.2

1.3

13.29
19.24
11.10
15.75
19.31
12.18
11.96
18.87

15.2

4.1

(MPa)

(Vol.%)

0.0

1
2
3
4
5
6
7
8

11.45
9.57
7.97
12.35
8.15
7.55
13.71
12.75

0.2

1
2
3
4
5
6
7
8

10.84
9.56
11.01
12.45
8.34
11.22
9.92
13.97

0.3

1
2
3
4
5
6
7
8

15.77
13.34
14.27
11.87
10.95
15.75
11.46
13.62

0.4

1
2
3
4
5
6
7
8

14.94
16.56
14.78
13.98
15.63
13.75
16.46
12.87

Flexural
Modulus
(GPa)

10.4

10.9

13.4

14.9
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The fracture toughness of scaffolds with varying vol. % of titanium fibers is
summarized in Table 3.3. The scaffolds with a 0.4 vol. % of titanium fibers were found to
have the highest fracture toughness (~0.8 MPa•m1/2 ) and those without fibers had a
toughness of ~0.5 MPa•m1/2. This trend indicates that the fracture toughness increases in a
manner similar to that observed in flexural strength when the amount of fibers in the
scaffold increases. The fracture toughness of scaffolds with varying vol. % of fibers with
their standard deviation is summarized in Table 3.3. The trend in increase of toughness
combined with increase in flexural modulus clearly shows that the mechanical properties
are increasing with addition of fibers in the scaffolds.
Table 3.3. Fracture toughness of scaffolds with varying vol. % of fibers
Fiber Volume
#
Fracture Toughness
Average
Standard
1/2
Fraction (Vol. %)
(MPa.m )
Deviation

0.0

0.2

0.3

0.4

1
2
3
4
5
6
1
2
3
4
5
6
1
2
3
4
5
6
1
2
3
4
5
6

0.42
0.48
0.50
0.46
0.44
0.50
0.58
0.55
0.61
0.70
0.56
0.52
0.61
0.65
0.77
0.48
0.90
0.77
0.81
0.73
0.89
0.71
0.85
0.76

0.47

0.03

0.59

0.06

0.71

0.13

0.79

0.07
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Studies have shown that the mechanical properties of borosilicate glass matrix
improved (five-fold improvement in fracture toughness to 3.85 MPa.m1/2) due to addition
of Hastelloy X fibers (15 vol. %) in them [25]. XPS analysis performed on the fibers
showed a presence of TiO2 on the surface of the Ti fibers. The presence of a layer of TiO2
could aid in bonding of the Ti fiber with the 13-93 bioglass matrix which predominantly
consists of several oxides including SiO2. In addition, the rough and uneven surface of Ti
fiber assists the bioglass matrix to better bond with the Ti fibers. An increased adhesion
between the glass matrix and the Ti fibers will increase the strength of scaffolds [37].
Below a fine layer of TiO2 on surface of the fibers, pure elemental Ti is present at the core.
The Ti fibers have an average tensile strength in the range from 246 to 370 MPa which
would help reinforce the brittle glass matrix by transferring the bending stresses from the
matrix to the fibers [36, 25].

In this study, titanium fibers were added during the production of paste and not
during the fabrication process. This type of pre-impregnation creates a homogenous matrix,
which in turn increases the strength considerably as compared to when the fibers are added
manually. The thermal expansion coefficients of the 13-93 bioglass and the titanium fibers
were 8.6 x 10-6 m/m K and 10.2 x 10-6 m/m K, respectively. After sintering, the glass matrix
will be in contraction and the Ti fibers will be in tension, preserving the bond between the
matrix and fiber. An enhanced matrix-fiber adhesion can modify the character of local
stresses. It can also impact the connectivity of the yielded micro zones adjacent to
neighboring fibers resulting in an increase of the mechanical properties of the scaffolds
[38].
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The addition of fibers improves the resistance of the scaffolds to crack propagation.
There are basically three possibilities once the crack reaches a fiber: (i) The crack
propagates through the fiber either by breaking the fiber or by plastic deformation; (ii)
deflection of the crack due to the fiber, and along a weaker fiber-matrix interface; and (iii)
a localized de-bonding occurs at the fiber-glass interface and the crack propagation energy
is dissipated, resulting in delayed/no crack propagation.

As to better understand crack propagation, pressed pellets (with bioactive glass and
fibers) were fabricated. On the pellets, indents were made using a Vickers indenter (Struers
Duramin-500, Cleveland, OH) and the propagation of cracks was studied using an optical
microscope. Figure 3.10 reveals that the fiber delays the growth of crack through it. In
addition Figure 3.10 shows a crack deflecting along the fiber-matrix interface and finally
propagating through it. This kind of ‘deflections’ are also effective toughening mechanisms
as they delay the crack propagation. The arrows in the Figure 3.10 shows the deflections
in crack near the fiber.

Figure 3.10. Crack deflections resulting in delay of crack growth through the glass matrix
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3.3. IN-VITRO EVALUATION OF SCAFFOLDS

Degradation of compressive strength of scaffolds, both with and without fibers as
a function of immersion time in SBF can be seen in Figure 3.11. The compressive strength
of scaffolds without fibers, before immersion, was 103 ± 33 MPa. This strength was
reduced to 67 MPa (reduction by ~30 %) after the scaffolds were immersed in SBF for four
weeks. This reduction is in accordance with similar studies conducted previously [17]. The
scaffold’s strength with fibers, before immersion, was 128 ± 30 MPa. This strength was
reduced by ~39% after 4 weeks to 88 MPa. The compressive strengths obtained (before
immersion into SBF) are similar to that of human cortical bone [34, 35]. The scaffolds lost
weight when hydroxyapatite was formed on the surface and elements dissociated into the
SBF solution. The weight loss of scaffolds, both with and without fibers as a function of
immersion time is given in Figure 3.12. The weight loss in the first two weeks was ~ 8%,
because of hydroxyapatite formed on the fresh surface. The weight loss decreased in the
third and fourth week (~ 3%). This trend is similar to that observed in compressive strength.
This weight loss could also be a potential reason behind the reduction in compressive
strength in-vitro.

Figure 3.11. Variation in the compressive strength of: (a) scaffolds without fibers;
(b) with fibers, when immersed in SBF.
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Figure 3.12. Weight loss of scaffolds with and without fiber in SBF as a function of time.

The SEM images of a scaffold surface, with fibers immersed in SBF for two weeks
are given in Figure 3.13. A thick crystalline layer with cracks was formed on the surface.
Needle-like structures similar to that of hydroxyapatite were observed at a higher
magnification [13, 18, 23]. A fiber that pulled out of the glass matrix can be seen in Figure
3.13.c. Since the fiber was pulled out from the bioglass matrix, it had a bioglass residuals
on the surface. A hydroxyapatite like material can be seen at the tip of this fiber, mostly
due to conversion of bioglass residuals on the surface of the fiber. The XRD pattern that
was received after the scaffolds (both with and without fibers) were analyzed, had peaks
that matched to the reference synthetic HA (JCPDS 72-1243), as pictured in Figure 3.14.
The patterns for scaffolds with and without fibers were identical, likely because of the low
volume fraction of Ti fibers used.
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Figure 3.13. SEM images of (a) Surface of scaffolds after immersion in SBF for 2 weeks
at 1000X, (b) magnified image of the same surface at 10000X , (c) fiber on the surface of
the scaffold at 1000X, (d) needle like HA crystals formed on the surface at 33000X.

Figure 3.14. The XRD patterns of (a) the scaffold with 0.3 vol. % of fibers immersed in
SBF for 2 weeks and (b) the reference hydroxyapatite (JCPDS 72-1243).
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The results gathered from the ICP-MS test are listed in Table 3.4.

The

concentration of Ti in SBF solution after four weeks of immersion was 0.26 µg/L. It can
be seen that at the end of 2 weeks, the Ti concentration was 0.32 µg/L. The concentrations
listed are for a total of five scaffolds immersed in SBF. The titanium fibers on the surface
of the scaffold’s surface came into contact with the SBF solution during the initial four
weeks. In case of scaffolds immersed in SBF for both three and four weeks, the amount of
fibers on the surface that was exposed to SBF solution was low. This is the primary reason
behind low titanium ion concentration rates as compared to the scaffolds that were used in
the first two weeks.
Table 3.4 Titanium ion concentration in SBF solution
Sample
Quality control blank

Scaffolds with

1 week
2 weeks
3 weeks
4 weeks

Titanium concentration (µg/L)
<< 0.25
0.30
0.32
0.25
0.26

fibers immersed in
The
formation
of hydroxyapatite confirms the bioactivity of the scaffolds. When
SBF
for:
the bioglass scaffolds are placed in the SBF solution Na+, K+ and (SiO4)4- ions dissolve
into the solution. Hydroxyapatite is formed due to the reaction of CaO present in the
bioglass with phosphate ions in the SBF solution. In conversion of silicate based 13-93
bioglass, a thin layer of SiO2 is formed on the surface of scaffolds on exposure to SBF
solution. This primarily slows down the conversion rate after a few days as shown by the
weight loss data. Since the volume fraction of fibers added was low (0.3 vol.%), a
considerable difference in weight loss due to addition of fibers was not observed.
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The conversion of bioglass scaffolds into hydroxyapatite also results in the
reduction of its mechanical properties. This is shown by the reduction in the compressive
strength of the scaffolds (Figure 3.12). The reduction in the compressive strength of both
types of scaffolds, with and without fibers, is a desirable property of bone implants. The
scaffolds with fibers had average compressive strength of 88 MPa after being immersed in
the SBF solution for four weeks. The high strength (88 MPa) of the scaffolds, even after
immersion in SBF for four weeks, leads to the possibility that the scaffolds could be used
for load bearing applications.

A significant amount of titanium ions remained absent from the SBF solution even
after four weeks of immersion of the scaffolds (titanium ions in the solution for five
scaffolds was < 0.4 µg/L). Previous studies on Ti implants have shown that Ti surface on
exposure to body fluids (20 mL Hank’s solution of pH 4.0) , develops a thin coating of
titanium dioxide on its surface [39]. This provide high corrosion resistance and
biocompatibility to the titanium implant. Joesph et al. [40], studied the release of Ti ions
from titanium and TiAl6Nb7 samples (10 mm x 10 mm x 1 mm) in different body fluids
(20 mL Hank’s solution of pH 4.0) for an extended period of 12 weeks. The concentration
of Ti ions reported after 12 weeks was 0.6 mg/L. Fabian et al. [41] investigated the effect
of TiO2 nano particles injected intravenously into rat body on the normal functionality.
5 mg/kg of TiO2 was the dose used in this study. However no toxic effect was evident from
the experimental results. The study concluded that TiO2 at low concentration (< 5 mg/kg)
is not toxic and can be used safely in implants. Frisken et al. [42], studied the titanium
release into body organs after insertion of a screw implant into the mandibles of a sheep
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for 12 weeks. According to that study, minor elevations in Ti levels (300 ppb of Ti ) were
observed in the lungs and lymph nodes. But the concentration is unlikely to cause a health
problem. The study, however, warns using multiple implants, as the amount of Ti released
will be comparatively high as to cause a significant level of toxicity. The titanium ions
released into SBF solution in our study is < 0.4 µg/L, when compared to the amounts
mentioned above. The chances of a systemic effect due to the leaching out of titanium ions
from the fibers in the scaffolds at the current concentration should be negligible. The fibers
are likely to become embedded in the newly formed bone as the new bone grows through
the scaffolds.
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4. CONCLUSION

This study investigated the feasibility of fabricating titanium fiber reinforced 13-93
bioglass scaffolds using the freeform extrusion fabrication technique. Scaffolds reinforced
with 0.4 vol. % fibers had a fracture toughness of ~ 0.8 MPa•m1/2 and flexural strength of
~ 15 MPa. The fracture toughness of scaffolds with fibers increased by 70% compared to
that without fibers and the flexural strength increased by 40%. The in vitro assessment of
scaffolds revealed that the addition of biocompatible titanium fibers to the bioactive glass
reinforced the scaffold mechanically without inhibiting its bioactive properties. The
improved mechanical properties with compressive strengths of ~88 MPa even after four
week degradation in simulated body fluid shows the potential of the 13-93 bioglass+Ti
composite implants for load bearing bone repair applications.
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APPENDIX

Recipe for preparing 13-93 bioactive glass paste

1. Fill a 500 ml Nalgene bottle one-third of the way with zirconia media.
2. Weight out 110 g of attrition milled 13-93 bioactive glass into it.
3. Add 54 ml of water along with 1.13 ml of Darvan C to the above mixture.
4. Close the bottle and shake it by hand for a couple of minutes as to prepare a slurry.
5. Ball mill for ~18 hours at 40 rpm.
6. After the ball milling operation, connect the water jacket to water bath. Place the
beaker on top of a stir plate. Set the water bath to 70°C. Do not remove the bottle
off the ball mill until the water reaches 70°C.
7. Once the set temperature is reached, put a stir bar in the beaker and set it to speed
400 RPM. Pour the slurry into the water jacketed beaker. Make sure the media do
not fall into the beaker.
8. Cover the beaker with a watch glass.
9. While waiting for the water bath temperature to come back to 70°C, weigh out 3.5
g of Methocel.
10. Lifting the watch glass with one hand put a small amount of Methocel with a spatula
in the other hand. Cover the beaker with the watch glass while the Methocel added
is stirred into the slurry. Although the Methocel should be added slowly, the beaker
should not remain uncovered for long since that will lead to water evaporation and
the paste will not turn out as expected.
11. Once all the Methocel is added in, let the slurry stir for 5 minutes.
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12. Now weigh out the required amount of fibers (based on the Vol %
required) and add it slowly into the above mixture.
13. After 5 minutes, set the water bath to 20°C. Make sure to check on it every once in
a while. If a layer starts forming, stir the slurry with the spatula. The paste will start
setting. When the stir bar cannot possibly stir the paste, turn off the stir plate.
14. When the water bath reaches 20°C, use the spatula to put the paste in the Whip Mixer
container. Close it with the lid. Connect the vacuum line. Turn it on. Whip mix it for
5 minutes. Using a cooking spatula, scrape the paste off the blade. Whip mix it for
another 5 minutes. Let it cool for 2 minutes. Whip mix it another 5 minutes for a
total of 15 minutes.
15. Disconnect the vacuum line. Turn the Whip Mix on for a minute to clean the line
and lubricate the motor.
16. Using a cooking spatula put the paste in a bottle.
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